- Author: Kathy Keatley Garvey
Congratulations to UC Davis distinguished professor Walter Leal, the recipient of the Academic Senate's highly competitive 2024 Distinguished Faculty Research Award.
That makes three. Good things come in threes.
Leal is the first UC Davis faculty member to win all three of the Academic Senate's most coveted awards: in research, teaching, and public service. In 2020, the Academic Senate awarded him the Distinguished Teaching Award for Undergraduate Teaching, and in 2022 Distinguished Scholarly Public Service Award.
Leal, a member of the Department of Molecular and Cellular Biology since 2013 and former professor and chair of the Department of Entomology, commented: "Faculty at land-grant universities, like the University of California, have three hats labeled Teaching, Service, and Research. A significant challenge is to budget time to wear them equally and avoid the temptation to emphasize one part of the job over others. It is gratifying to be recognized by my peers as excelling in all areas. The Academic Senate Faculty Distinguished Research Award is particularly humbling because more than 3000 eligible faculty excel in all research areas on this campus. Why me? Because of my students, postdoctoral scholars, visiting scholars, collaborators, and colleagues. They deserve most of the credit for this honor. I accept it on their behalf. It is a team effort, like in a honey bee colony.”
"Walter is truly a renaissance man," wrote Hammock. "He chaired our entomology department from 2006 to 2008, and under his tenure, our department was ranked No. 1 in the country. I've long admired (1) his rigorous fundamental research programs supported by National Science Foundation, National Institutes of Health, and the U.S. Department of Food and Agriculture, and other agencies, (2) how he tackles and solves multiple challenging problems in insect olfaction and chemical ecology, (3) his grasp of how to organize and moderate highly successful worldwide research webinars (4) his generosity in helping other succeed and (4) his finely honed sense of humor."
“Walter has been exceptionally conscientious, active, and generous in professional service at UC Davis,” Hammock pointed out. “In August of 2021, he achieved a ‘first' for international science communication when he organized and led the extraordinary virtual conference ‘Insect Olfaction and Taste in 24 Hours Around the Globe.' I especially applaud him for elucidating the mode of action of the insect repellent DEET, developed in 1946 and known as ‘the gold standard of
repellents.' Its mode of action remained an enigma for six decades until Walter's discovery. Inresearching the neurons in mosquito antennae sensitive to DEET, he isolated the first DEET-sensitive odorant receptor, paving the way for the development of better repellents.”
Leal is a newly elected trustee of the Royal Entomological Society, the 13-member council that governs the 190-year-old international organization. He is the first UC Davis scientist to be elected a trustee. And he's chair of the Council of the International Congresses of Entomology, the body that ensures the continuity of the international congresses of entomology. He co-chaired the 2016 International Congress of Entomology, which drew 6,682 registrants from 102 countries to Orlando, Fla.
Among Leal's many honors: Fellow of the Entomological Society of America (2009), American Association for the Advancement of Science (2005), and the National Academy of Inventors (2019).
A native of Brazil, Leal joined the UC Davis entomology faculty in 2000, after serving as the head of the Laboratory of Chemical Prospecting, National Institute of Sericultural and Entomological Science (NISES), Ministry of Agriculture, Forestry, and Fisheries, Japan. In 2013, he accepted a position as professor of biochemistry, Department of Molecular and Cellular Biology. (See news story)
Frankly, we don't know how Leal does it all. He not only excels at research, teaching and public service, but he is widely known as "The UC Davis Ambassador," organizing campus-wide celebrations for faculty transitioning to emeriti.
As an aside, two UC Davis entomology faculty members scored two, but not three, of the Academic Senate's coveted awards. Bruce Hammock received the Distinguished Faculty Research Award in 2001, and the Distinguished Teaching Award (graduate student/professional category) in 2008. UC distinguished professor of entomology, James R. Carey, took home the Academic Senate's Distinguished Teaching Award (undergraduate student category) in 2014 and the Distinguished Scholarly Public Service Award in 2015.
Six other entomology faculty members have received Academic Senate awards:
- UC Davis distinguished professor Jay Rosenheim, Distinguished Teaching Award (undergraduate student category) in 2011
- UC Davis distinguished professor Lynn Kimsey (now emerita), Distinguished Scholarly Public Service Award in 2016
- UC Davis distinguished professor Frank Zalom, Distinguished Scholarly Public Service in 2017
- UC Davis professor and now department chair Joanna Chiu, Distinguished Teaching Award (graduate/professional category) in 2022
- UC Davis distinguished professor Diane Ullman, Distinguished Teaching Award (undergraduate category) in 2022
And the latest to join the winner's circle: Professor Louie Yang won the Distinguished Teaching Award (undergraduate category), announced today. More on this amazing teacher and mentor is pending.
- Author: Kathy Keatley Garvey
EicOsis Human Health LLC, the Davis-based pharmaceutical company developing a non-narcotic drug to relieve chronic pain and inflammation, today announced the next step in its ongoing human clinical trials: the initiation of Phase 1b to test the safety of its drug candidate, EC5026.
The ongoing double-blind, placebo-controlled Phase 1b study is designed to investigate the safety and pharmacokinetics of daily doses of EC5026 over seven days.
EC5026, an inhibitor of the soluble hydrolase enzyme (sEH), was discovered and patented at EicOsis based on previous patents and research papers from the laboratory of UC Davis distinguished professor Bruce Hammock during his half-century of research.
“EC5026 plays a crucial role in regulating the metabolism of signaling lipids and responding to inflammation and other stress responses caused by trauma or disease,” said Hammock, who holds a joint appointment with the Department of Entomology and Nematology and the UC Davis Comprehensive Cancer Center. “We found sEH to be a target for treating pain, inflammation, cancer and other diseases.”
By inhibiting sEH, EC5026 alleviates pain by preventing the breakdown of natural analgesic and anti-inflammatory fatty acids. Preclinical studies demonstrate no sedation or other adverse behavioral effects and no signs of addiction.
“Many regulatory molecules are controlled as much by degradation as biosynthesis,” Hammock explained. "The epoxy fatty acids rapidly degraded by the sEH control blood pressure, fibrosis,immunity, tissue growth, depression, pain, and inflammation, to name a few processes.”
“The initial results from Cohort 1 appear to replicate the very favorable safety profile we observed in our previous two Phase 1a clinical studies where there were no adverse behavioral, cardiovascular, or neurological effects over five ascending single-dose levels,” said Dr. William Schmidt, EicOsis vice president of clinical development. “The maximum dose level was 5 to 10-fold higher than the anticipated analgesic dose in humans.”
“If Cohort 2 dosing also proceeds without clinically significant adverse effects and a favorable pharmacokinetic profile for once-a-day dosing,” Schmidt continued, “this provides encouragement for initiating our first analgesic efficacy study in the second quarter of 2024.”
EicOsis plans to initiate its first pain patient study in April 2024 “to evaluate safety and analgesic effects in patients with a spinal cord injury who have failed to achieve satisfactory pain relief with existing non-opioid chronic pain medications,” said Cindy McReynolds, EicOsis chief executive officer and former director of research.
“Initiation of the Phase 1b program represents a significant milestone for EicOsis Human Health and demonstrates the success and dedication of our team to make this happen,” said McReynolds, who holds a doctorate in pharmacology and toxicology from UC Davis. “Demonstrating safety in Phase 1b studies will allow us to evaluate efficacy in patients and bring forward safe and effective treatments for several serious diseases. For example, the sEH inhibitors are being considered for use for treatment of cancer in the UC Davis Comprehensive Cancer Center, and neurological disease through the UC Davis Health's designated Parkinson's Foundation Center of Excellence.”
“As a potential anti-inflammatory fatty acid, EC5026 holds promise in addressing neuroinflammation, a key factor in the manifestation and even progression of Parkinson's,” said Zhang, who holds both an M.D. and a PhD. “Ensuring its safety profile in healthy individuals is fundamental for establishing a foundation for further clinical trials. this investigation provides valuable insights into design and overall safety parameters, paving the way for the next stages in advancing this innovative therapeutic approach for Parkinson's disease."
The FDA granted Fast Track status to EC5026 in April 2020 to support the unmet medical need for safe and effective non-opioid analgesics. EicOsis clinical scientist Irene Cortés Puch, who authored the successful application, commented: “Both our commitment and focus at EicOsis Human Health are guided by a genuine concern for the well-being of patients and recognizing the importance of identifying effective pain management alternatives. Therefore, the initiation of this Phase 1b clinical trial is an exciting step in advancing our mission to provide safer and effective treatments.”
Hammock traces his research on chronic pain to his earlier work on how a caterpillar becomes a butterfly; a key enzyme, epoxide hydrolase, degrades a caterpillar's juvenile hormone, resulting in metamorphosis.
A member of the UC Davis faculty since 1980, Hammock founded ;EicOsis in 2011 and served as its chief executive officer until February 2023 when he transitioned to scientific officer and chairman of the board of directors. Highly honored by his peers, he is a member of the National Academy of Inventors and the National Academy of Sciences and received the 2020 Lifetime Achievement Award in Innovation from UC Davis Chancellor Gary May. Hammock has authored or co-authored more than 1400 peer-reviewed publications and holds more than 95 patents in agriculture, environmental science and medicinal chemistry.
EicOsis (pronounced eye-co-sis), derives its name from eicosanoids, “the major backbone of chemical mediators in the arachidonate cascade,” McReynolds said. “It symbolizes the epoxide group in chemistry, which is key to the anti-inflammatory chemical mediators and where the biochemical target called soluble epoxide hydrolase works.”
Approximately 50 million Americans (20 percent of the population) suffer from chronic pain, according to the Centers for Disease Control and Prevention. The annual economic toll is $560 billion, encompassing direct medical expenses, lost productivity, and disability claims.
More information on the Phase 1b multiple-ascending dose clinical study is available at https://clinicaltrials.gov/study/NCT06089837.
- Author: Kathy Keatley Garvey
Hammock, internationally recognized for discovering a new group of human chemical mediators, is a newly inducted Fellow of the California Academy of Sciences (CAS). (He's also our favorite to some day win the Nobel Prize, as we've told him many times!)
Hammock, who holds a joint appointment with the Department of Entomology and Nematology and the UC Davis Comprehensive Cancer Center, was inducted along with 13 other Fellows on Nov. 14 during the annual Fellowship meeting. He joins the ranks of more than 500 Academy Fellows, a governing group of distinguished scientists and other leaders who have made notable contributions to scientific research, education, and communication.
“We're proud to announce 2023's distinguished pool of new Fellows—each of their contributions to science and society represent major advancements in their respective fields,” said Academy Dean of Science and Research Collections Shannon Bennett. “Our Fellows body is a group of future thinkers and innovators whose leadership inspires the next generation of scientists, science educators, story-tellers and change-makers. We look forward to forging a future with our new Fellows that advances the Academy's mission to regenerate the natural world through science, learning, and collaborative partnerships.”
A member of the UC Davis faculty since 1980, Hammock was nominated by colleagues James R. Carey, UC Davis distinguished professor, and Robert E. Page Jr., UC Davis distinguished emeritus professor and emeritus provost of Arizona State University. The CAS Board of Trustees selects the Fellows.
Hammock discovered that regulating degradation of insect hormone mediators is as important as biosynthesis in development. He applied this toward the development of green chemical and the first recombinant viral pesticide. He asked if the same systems of metabolism of chemical mediators could be important in other species, notably man, resulting in the discovery of a new group of human chemical mediators. By inhibiting a key enzyme in this pathway, beneficial natural mediators increased there by showing benefit in treating multiple diseases including arthritis, cancer, Alzheimer's with the resulting drug candidates currently in human trials to treat pain.
Hammock founded the Davis-based pharmaceutical company, EicOsis LLC, formed in 2011 to develop an orally active non-addictive drug for inflammatory and neuropathic pain. The former chief executive officer, he now serves on the board of directors.
Hammock directed the UC Davis Superfund Research Program (funded by the National Institutes of Health's National Institute of Environmental Health Sciences) for nearly four decades, supporting scores of pre- and postdoctoral scholars in interdisciplinary research in five different colleges and graduate groups on campus.
He is a fellow of the National Academy of Inventors and the National Academy of Sciences., and the Entomological Society of America. He is the recipient of scores of awards, including the first McGiff Memorial Awardee in Lipid Biochemistry; and the Bernard B. Brodie Award in Drug Metabolism, sponsored by the America Society for Pharmacology and Experimental Therapeutics. At UC Davis he received the Distinguished Teaching Award and the Faculty Research Lectureship. In 2020, he received a Lifetime Achievement Award from UC Davis Chancellor Gary May.
Hammock is known for his expertise in chemistry, toxicology, biochemistry and entomology. Early in his career, he founded the field of environmental immunoassay, using antibodies and biosensors to monitor food and environmental safety, and human exposure to pesticides. His groundbreaking research in insect physiology, toxicology led to his development of the first recombinant virus for insect control.
A native of Little Rock, Ark., Hammock received his bachelor's degree in entomology (with minors in zoology and chemistry) magna cum laude from Louisiana State University, Baton Rouge, in 1969. He received his doctorate in entomology-toxicology from UC Berkeley in 1973. Hammock served as a public health medical officer with the U.S. Army Academy of Health Science, San Antonio, and as a postdoctoral fellow at the Rockefeller Foundation, Department of Biology, Northwestern University, Evanston, Ill.
In the Army, he served as a medical officer at Fort Sam, Houston, and what he saw--severely burned people in terrible pain--made a lasting impression on him and steered him toward helping humankind.
Fun Fact: For years Hammock--who believes science should be fun and camaraderie is crucial-- hosted water balloon battles on the Briggs Hall lawn. It was not "Fifteen Minutes of Fame"; it was "Fifteen Minutes of Aim." See Bug Squad blog.
Check out UC Davis distinguished professor Walter Leal's video of the Fellows' induction. (A screen shot is below) Leal is on X (used to be Twitter) at @wsleal2014.
- Author: Kathy Keatley Garvey
The research involves the development of a DNA-based sensor amplification system demonstrated in a fluorescence immunoassay that can detect, both simply and rapidly, trace amounts of organophosphate pesticides (OPs) in food products.
The paper, “Competitive Fluorescent Immunosensor Based on Catalytic Hairpin Self-Assembly for Multiresidue Detection of Organophosphate Pesticides in Agricultural Products,” appeared in the February edition of the Food Chemistry journal and is republished in June as “Paper of the Month."
Maojun Jin, who served a year (September 2019 to September 2020) as a visiting scholar in the Hammock laboratory, UC Davis Department of Entomology and Nematology, led the research team, and is the senior author and corresponding author. He is now a professor in the Institute of Quality Standards and Testing Technology for Agro-Products, Chinese Academy of Agricultural Sciences. His doctoral student, Yuanshang Wang, is the first author.
“I'm very proud of what Maoiun and his team have accomplished,” said Hammock, who directs the NIEHS-UC Davis Superfund Research Program. The research was partially funded by his Superfund grant, and his NIEHS RIVER (Revolutionizing Innovative, Visionary Environmental Health Research) Award.
In addition, the research drew financial support from the National Natural Science Foundation of China, Central Public-interest Scientific Institution Basal Research Fund, and the Central Public Interest Scientific Institution Basal Research Fund for the Chinese Academy of Agricultural Sciences.
(See full story on the UC Davis Department of Entomology and Nematology website. No images can currently be loaded on the Bug Squad blog due to server issues.)
- Author: Kathy Keatley Garvey
Congrats to UC Davis undergraduate entomology major Rachel Shey, a research assistant in the laboratory of UC Davis Distinguished Professor Bruce Hammock, who won not only the poster competition, but more importantly, the $5000 Francesca Miller Undergraduate Research Award that will fund six weeks of full-time summer research.
Well done, Rachel!
The symposium, sponsored by the Department of Chemistry and recently held in the UC Davis Conference Center, featured cutting-edge research in chemical biology, organic, and pharmaceutical chemistry. It memorializes Professor Miller (1940-1998) the 1985-90 chair of the Department of Chemistry and the 1997-1998 chair of the Academic Senate.
“We're very proud of Rachel,” said Hammock, who holds a joint appointment with the Department of Entomology and Nematology and the UC Davis Comprehensive Cancer Center. “Rachel winning the undergraduate research award as well as the first-place award for her poster on her research—that's no surprise. She is enthusiastic about science and has wonderful collaborations with our scientists. She is one of those rare people who can cross disciplines, and in this case, integrate molecular biology, chemistry, and analytical chemistry to address a serious problem in the world food supply. Not only that, but she makes the lab had more fun place to be.”
In her abstract, co-authored with mentor Hammock and project scientist Mark McCoy of the Hammock lab, Shey wrote:
“Have you ever forgotten about a bagel on the counter and come back a few days later to find that it has grown a thin layer of fuzzy green mold? Most people know not to eat it, but why not? Aspergillus fungus produces a toxin called aflatoxin, which is the reason moldy bread, bitter peanuts and other foods may not be safe to eat. Aspergillus grows on virtually all major crops in the world, and aflatoxin is present wherever Aspergillus grows.”
“I am developing a nanobody-based immunoassay for the detection of aflatoxin B1 in the matrix of hemp bud, intended to simulate cannabis. Nanobodies, also known as VHHs (heavy chains) represent a new technology. They are small antibodies which are derived from camelids and sharks. Unlike regular antibodies, nanobodies are made of only heavy chains and are therefore about ten times smaller than traditional monoclonal antibodies or polyclonal antibodies. Because nanobodies are encoded on a single polypeptide chain, they can be grown in E. coli cheaply and in large amounts.”
“Cannabis is highly regulated in California,” Shey pointed out, “but batches of cannabis that fail testing are usually sold on the black market rather than at a regulated dispensary. Consumers who decide to run the risk of purchasing cannabis from an unregulated seller would also benefit from immunoassays for monitoring the levels of various pesticides and known contaminants, including aflatoxin. This immunoassay could be useful for not only commercial labs analyzing cannabis, but also consumers purchasing cannabis illegally.”
Shey also presented her poster research at two other UC Davis conferences this year: the Undergraduate Research, Scholarship and Creative Activities Conference (URSCA) and the 2023 Richard LaRock Conference.
“I was really drawn to entomology because I've loved playing with insects ever since I was a kid,” Rachel said. “When I took organic chemistry, I fell in love with the unique style of problem solving and I grew passionate about its practical aspects as well.”
In the Hammock lab, she helps in immunoassay experiments, delivers presentations to the lab, and learns about research and science. “I am developing proficiency with ELISA (enzyme linked immunosorbent assay) and phage work,” Shey said. She is working on an independent project funded by an Innovation Institute for Food and Health Undergraduate Research Fellowship (IIFL) from the UC Davis Undergraduate Research Center. It involves the detection of aflatoxin in mouse brain tissue.
Shey also is a research assistant (since November 2022) in the lab of Cody Ross Pitt, assistant professor, UC Davis Department of Chemistry, where she is learning organic synthesis methods, including setting up air-sensitive reactions, working up reactions, using columns to purify the crude material, and operating a rotary evaporator (rotovap).
She has served a general and organic chemistry tutor or the UC Davis Academic Assistance and Tutoring Center (AATC) since September 2021. She staffs the drop-in area in the library and the online Zoom drop-in room for several hours each week. “I assist students with chemistry questions with the goal of helping my students develop study skills.”
Shey also worked part-time for almost two years as a city news reporter for the California Aggie, the UC Davis student-run newspaper.
Her career plans: to study organic chemistry and obtain a doctorate in chemistry. “I would love to work in medicinal chemistry or agrochemistry.”
“When I first talked to her she was excited over epoxides as such interesting chemical functionalities,” said Hammock, known for his expertise in chemistry, toxicology, biochemistry and entomology. Early in his career, he founded the field of environmental immunoassay, using antibodies and biosensors to monitor food and environmental safety, and human exposure to pesticides. His groundbreaking research in insect physiology, toxicology led to his development of the first recombinant virus for insect control.
“I saw Barry Sharpless last week, who like Linus Pauling, won two Nobel Prizes," Hammock said. She reminds me of Barry. The world needs more undergrads like Rachel.”